Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
US10167286B2 · kind B2 · utility
5Cited by
15References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2015 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Feb 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure is directed to compounds and pharmaceutically acceptable salts thereof for the treatment and/or prevention of neurodegenerative and/or mitochondrial diseases, such as Parkinson's disease and Leigh's disease. The compounds and pharmaceutically acceptable salts thereof are of the class of nitrogenous bases, for example, pyrimidines, purines, pteridines and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.